Rocket


Overview
Financials
News + Filings
Key Docs
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Structure Therapeutics Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20
   S-1/AS-1/A
Revenues  29.112.4
            Revenue growth  135.4% 
Cost of goods sold  37.715.9
Gross profit  -8.6-3.5
            Gross margin  -29.5%-28.6%
Selling, general and administrative   [+]8.63.5
Other operating expenses  20.58.8
EBITDA   [+]-37.6 
            EBITDA margin  -129.2%-128.6%
Depreciation and amortization  0.1 
EBIT   [+]-37.7-15.9
            EBIT margin  -129.5%-128.6%
Other income (expense), net  -0.10.2
Pre-tax income  -37.8-15.7
Income taxes  0.20.1
Net income  -38.00.0
            Net margin  -130.7%0.0%
   
   
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy